Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 09-27-2011, 02:14 AM #5
zorro1 zorro1 is offline
Member
 
Join Date: Jul 2008
Posts: 390
15 yr Member
zorro1 zorro1 is offline
Member
 
Join Date: Jul 2008
Posts: 390
15 yr Member
Default

As mention its good and usually the first choice med for P/N.

Disadvantages
weight gain, this is real problem for diabetics and any anyone with foot P/n since your weight is supported by a small surface area along the soles of your feet so more weight=more painful walking.

Brain fog, which is okay if your retired or have a low profile job but if your the CEO it may be difficult.

Effectiveness which varies from person to person but the drug may require increase dosage as your body builds up a tolerance.
zorro1 is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
here2hear (10-17-2011)
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Gabapentin roadrunner63 Traumatic Brain Injury and Post Concussion Syndrome 14 01-21-2012 06:19 PM
Gabapentin drwk Peripheral Neuropathy 7 08-29-2011 12:31 PM
Gabapentin diane54 Thoracic Outlet Syndrome 4 03-03-2011 05:07 PM
Gabapentin? TrevorL Trigeminal Neuralgia 4 01-13-2010 12:18 PM
Gabapentin creative Medications & Treatments 10 01-10-2010 02:48 AM


All times are GMT -5. The time now is 12:40 AM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.


Always consult your doctor before trying anything you read here.